CPMD 8-K
Cannapharmarx, Inc. (CPMD)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM
__________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): [DATE]
__________________________
(Exact name of registrant as specified in its charter) |
__________________________
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices, including zip code)
(
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
__________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
|
| OTC Markets |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
CannaPharmaRX, Inc. ("the "Company") issued a press release on May 6, 2025 announcing updates on orders fulfilled from customers in Germany and Israel. A copy of the press release is provided as Exhibit 99.1 to this Current Report.
Item 9.01 Exhibits.
Exhibit No. |
| Description |
|
|
|
| ||
104 |
| Cover Page Interactive Data File (embedded within the Inline XBRL document) |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CANNAPHARMARX, INC. |
| |
| |||
May 6, 2025 | By: | /s/ Constantine Nkafu |
|
| Name: | Constantine Nkafu |
|
| Title: | CEO |
|
3 |
EXHIBIT 99.1
CannapharmaRx Continues into New European Market with First Shipment Completed to Germany
CannaPharmaRX, Inc. (OTC PINK: CPMD), a future leader in cannabis cultivation, is pleased to share recent updates, including its latest cultivation activities and sales achievements.
Successful Shipments to Israel and Germany
To date, the Company has successfully completed four shipments to Israel and one to Germany. Customer satisfaction with our proprietary strains remains high, and we are seeing strong demand for continued shipments in 2025.
Below is a summary of shipment volumes and average pricing:
• First Shipment to Israel (2024) – 150 Kg – Avg. price: 1.20 CAD/gram
• Second Shipment to Israel (2024) – 150 Kg – Avg. price: 1.57 CAD/gram
• Third Shipment to Israel (Jan 2025) – 245.7 Kg – Avg. price: 1.83 CAD/gram
• Fourth Shipment to Israel (April 2025) – 118.667 Kg – Avg. price: 1.90 CAD/gram
• First Shipment to Germany (March 2025) – 227.5 Kg – Avg. price: 1.94 CAD/gram
Additionally, the Company acted as an intermediary for other Canadian growers, facilitating deliveries to Israeli clients. This included 54.26 Kg in the third shipment and 73.17 Kg in the fourth. This new revenue stream reinforces the Company’s role as a key international hub, offering access to the German market for producers who may not have direct entry themselves.
Upcoming Shipments to Germany
The Company plans to make a second shipment to Germany in June, estimated at approximately 241 Kg. The anticipated pricing is 1.82 CAD/gram for product with less than 21% THC and 2.04 CAD/gram for product with more than 21% THC.
Ongoing Cannabis Cultivation
The Company is currently cultivating only 5 out of the existing 10 rooms. Additional capital expenditures are planned for 2025 to turn on the remaining 5 rooms and to add a new drying room to accommodate.
The Company also notes that, following changes to the growing method and post-harvest process to produce higher-quality products, it expects each grow room to yield approximately 60–80 Kg per month, with an average monthly forecast of 150 Kg and estimated sales in excess of CAD$300,000 per month.